{"id":39752,"date":"2024-07-02T13:28:55","date_gmt":"2024-07-02T07:58:55","guid":{"rendered":"https:\/\/www.equentis.com\/blog\/?p=39752"},"modified":"2025-11-07T11:56:58","modified_gmt":"2025-11-07T06:26:58","slug":"1952-cr-emcure-pharma-ipo-opens-july-3rd-a-deep-dive-into-swot-gmp","status":"publish","type":"post","link":"https:\/\/www.equentis.com\/blog\/1952-cr-emcure-pharma-ipo-opens-july-3rd-a-deep-dive-into-swot-gmp\/","title":{"rendered":"\u20b91952 Cr Emcure Pharma IPO Opens July 3rd: A Deep Dive into SWOT, GMP and More"},"content":{"rendered":"
<\/div>\n

The IPO bandwagon continues to roll, and July is set to welcome one of its biggest offerings yet. Emcure Pharmaceuticals, a leading Indian pharma company with a global<\/a> presence, is aiming to raise a significant \u20b91,952.03 crore through its initial public offering. But before you jump on the IPO<\/a> train, let’s take a closer look at the details and analyze the company’s strengths and weaknesses to help you make an informed decision.<\/p>\n\n\n\n


<\/strong>Emcure Pharmaceuticals IPO details<\/h2>\n\n\n\n
Offer Price<\/td>\u20b9960 \u2013 \u20b91008 per share<\/td><\/tr>
Face Value<\/td>\u20b910 per share<\/td><\/tr>
Opening Date<\/td>3 July 2024<\/td><\/tr>
Closing Date<\/td>5 July 2024<\/td><\/tr>
Total Issue Size (in Shares)<\/td>19,365,346 <\/td><\/tr>
Total Issue Size (in \u20b9)<\/td>\u20b91952.03 Cr<\/td><\/tr>
Issue Type <\/td>Book Built Issue IPO<\/a><\/td><\/tr>
Lot Size<\/td>14 Shares<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Breaking Down the IPO<\/strong><\/h2>\n\n\n\n

Emcure’s IPO<\/a> is a book built issue, meaning the demand will determine the final price within a specified range. The issue is divided into two parts: a fresh issue of \u20b9800 crore to raise new capital and an offer for sale (OFS) of \u20b91,152.03 crore by existing shareholders.<\/p>\n\n\n\n


Investing in an IPO requires understanding the minimum lot size, which in this case is 14 shares. You can bid for multiples of 14 shares. The price band has been set between \u20b9960 and \u20b91008 per share.<\/p>\n\n\n\n

Who Gets What? Understanding IPO Allocation<\/strong><\/h2>\n\n\n\n

Emcure has divided the IPO pie strategically. Here’s how the shares will be distributed:<\/p>\n\n\n\n